Figure 2.Treatment with PHN-20 alleviated hypoxia-induced pulmonary vascular remodeling in rats. The percentage of pulmonary arterial wall thickness (W%) was calculated. (*, P<0.05 vs. control group; #, P<0.05 vs. hypoxia group).
Figure 2 — Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress | Aging
